Breaking News Instant updates and real-time market news.

FIVE

Five Below

$39.12

-0.2 (-0.51%)

07:10
03/21/17
03/21
07:10
03/21/17
07:10

Five Below's long-term outlook remains compelling, says MKM Partners

MKM Partners analyst Patrick McKeever maintained his Buy rating and $51 price target on Five Below ahead of Q4 results tomorrow. He expects the quarter to be largely in-line with management's pre-ICR update on January 9 and to show a late-holiday pickup and a solid January following a softer mid-December. McKeever believes new store productivity remains on track north of 90% and ROI remains near 100% for year-one. The analyst continues to view Five Below as one of the most compelling long-term retail growth stories.

  • 22

    Mar

  • 20

    Jun

FIVE Five Below
$39.12

-0.2 (-0.51%)

10/26/16
10/26/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Mylan (MYL) initiated with a Buy at Mizuho. 2. Five Below (FIVE) initiated with a Buy at Longbow. 3. NetSuite (N) reinstated with an Underperform at BofA/Merrill. 4. Adient (ADNT) initiated with a Buy at Northcoast. 5. Party City (PRTY) initiated with a Neutral at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/02/16
RBCM
12/02/16
NO CHANGE
RBCM
Five Below reported 'impressive' results, says RBC Capital
After Five Below reported lower than expected Q3 comp sales, RBC Capital analyst Scot Ciccarelli blames the miss on pre-election worries and notes that the company's revenue came in close to his $201M estimate while trends improved last month and margins beat expectations. The analyst remains upbeat on the company's longer term outlook and recommends buying the stock.
01/10/17
RBCM
01/10/17
NO CHANGE
RBCM
Five Below shares should be bought on weakness, says RBC Capital
After Five Below's holiday sales came in below expectations, RBC Capital analyst Scot Ciccarelli remains upbeat on the company's long-term " store growth potential and highly favorable unit economics." He believes that the stock's valuation is attractive and recommends buying the stock on weakness but trimmed his price target on the shares to $50 from $54.
01/11/17
SBSH
01/11/17
NO CHANGE
Target $50
SBSH
Buy
Citi sees buying opportunity into Five Below
After meeting with the company at the ICR Conference, Citi analyst Alvin Concepcion thinks an "enhanced buy opportunity still exists" for shares of Five Below. The company's softer than expected same-store-sales in Q4 had a limited impact to profitability and doesn't change the long-term growth prospects, Concepcion tells investors in a research note. He believes Five Below's growth prospects are underappreciated and keeps a Buy rating on the shares with a $50 price target.

TODAY'S FREE FLY STORIES

FDS

FactSet

$185.76

3.5 (1.92%)

07:39
10/23/17
10/23
07:39
10/23/17
07:39
Recommendations
FactSet analyst commentary  »

FactSet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVOK

Evoke Pharma

$3.44

0.07 (2.08%)

07:39
10/23/17
10/23
07:39
10/23/17
07:39
Hot Stocks
Evoke Pharma announces topline results from comparative exposure PK study »

Evoke Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:38
10/23/17
10/23
07:38
10/23/17
07:38
Conference/Events
JPMorgan to hold a forum »

Japan FinTech Forum is…

07:38
10/23/17
10/23
07:38
10/23/17
07:38
Conference/Events
Piper Jaffray to hold a field trip »

Brazilian Agricultural…

EFX

Equifax

$109.97

-0.54 (-0.49%)

07:38
10/23/17
10/23
07:38
10/23/17
07:38
Downgrade
Equifax rating change  »

Equifax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 14

    Dec

CX

Cemex

$7.96

-0.13 (-1.61%)

07:37
10/23/17
10/23
07:37
10/23/17
07:37
Upgrade
Cemex rating change  »

Cemex upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$56.32

0.32 (0.57%)

, MD

Mednax

07:36
10/23/17
10/23
07:36
10/23/17
07:36
Conference/Events
American Society of Anesthesiology to hold annual meeting »

Anesthesiology 2017…

ABT

Abbott

$56.32

0.32 (0.57%)

MD

Mednax

ABBV

AbbVie

$96.10

-0.38 (-0.39%)

BAX

Baxter

$63.59

0.12 (0.19%)

CAE

CAE

$17.43

0.01 (0.06%)

DDD

3D Systems

$12.00

0.53 (4.62%)

EM

Emdeon

XENE

Xenon Pharmaceuticals

$3.25

0.05 (1.56%)

TRVN

Trevena

$1.76

0.1 (6.02%)

SIEGY

Siemens

$68.33

-1.245 (-1.79%)

NOVA

NovaMed

NUVA

NuVasive

$55.05

0.48 (0.88%)

PFE

Pfizer

$36.42

0.18 (0.50%)

INFI

Infinity Pharmaceuticals

$2.28

-0.12 (-5.00%)

KRO

Kronos Worldwide

$26.17

0.35 (1.36%)

MNK

Mallinckrodt

$32.42

-0.4 (-1.22%)

HAE

Haemonetics

$45.66

0.55 (1.22%)

EW

Edwards Lifesciences

$113.08

1.05 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 27

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 07

    Dec

CMCSA

Comcast

$37.22

0.32 (0.87%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Recommendations
Comcast analyst commentary  »

Comcast video losses do…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 01

    Nov

ENTA

Enanta

$48.16

0.76 (1.60%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Hot Stocks
Enanta announces 'positive' Phase 1 a/b clinical results for EDP-305 »

Enanta Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark sees FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

VZ

Verizon

$49.53

0.32 (0.65%)

, UNP

Union Pacific

$112.99

0.98 (0.87%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

VZ

Verizon

$49.53

0.32 (0.65%)

UNP

Union Pacific

$112.99

0.98 (0.87%)

S

Sprint

$6.93

-0.14 (-1.98%)

PYPL

PayPal

$70.97

3.72 (5.53%)

CTL

CenturyLink

$19.04

0.55 (2.97%)

NSC

Norfolk Southern

$132.75

2.51 (1.93%)

FEYE

FireEye

$16.81

-0.01 (-0.06%)

AMTD

TD Ameritrade

$48.27

0.88 (1.86%)

PRU

Prudential

$110.78

1.18 (1.08%)

AVP

Avon Products

$2.28

0.02 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 07

    Nov

  • 07

    Nov

  • 15

    Nov

  • 29

    Nov

  • 07

    Dec

  • 16

    May

MRK

Merck

$63.88

0.13 (0.20%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

07:34
10/23/17
10/23
07:34
10/23/17
07:34
Conference/Events
World Congress to hold a summit »

5th Annual Patient…

MRK

Merck

$63.88

0.13 (0.20%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

PFE

Pfizer

$36.42

0.18 (0.50%)

AGN

Allergan

$188.28

-0.99 (-0.52%)

ONCE

Spark Therapeutics

$81.87

1.08 (1.34%)

PODD

Insulet

$61.58

-0.39 (-0.63%)

ACHN

Achillion

$4.15

-0.01 (-0.24%)

SNY

Sanofi

$49.51

-0.51 (-1.02%)

ABEO

Abeona Therapeutics

$19.00

1.25 (7.04%)

JNJ

Johnson & Johnson

$142.40

0.36 (0.25%)

AZN

AstraZeneca

$34.62

-0.09 (-0.26%)

SHPG

Shire

$145.25

-2.57 (-1.74%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

BMY

Bristol-Myers

$64.42

-0.25 (-0.39%)

SCMP

Sucampo

$10.30

0.05 (0.49%)

PCRX

Pacira

$33.50

0.4 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 16

    Nov

  • 30

    Nov

  • 12

    Jan

  • 02

    Feb

  • 05

    Mar

  • 06

    Apr

AAPL

Apple

$156.25

0.27 (0.17%)

07:34
10/23/17
10/23
07:34
10/23/17
07:34
Recommendations
Apple analyst commentary  »

Apple supply/demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Hot Stocks
T-Mobile raises low end of postpaid net custuomer adds view to 3.3M-3.6M »

T-Mobile says, "We…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Hot Stocks
Kimberly-Clark says Q3 a 'challenging environment' »

Chairman and CEO Thomas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Conference/Events
The U.S. Commodity Futures Trading Commission holds a symposium »

25th Annual Symposium is…

BKS

Barnes & Noble

$7.35

0.15 (2.08%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Conference/Events
Barnes & Noble management to meet with Sidoti »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Hot Stocks
T-Mobile sees FY branded postpaid phone ARPU 'generally stable' to FY16 »

T-Mobile continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

DCPH

Deciphera

$20.15

0.31 (1.56%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Initiation
Deciphera initiated  »

Deciphera initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Earnings
Kimberly-Clark backs FY17 EPS view at low end of $6.20-$6.35 »

FY17 consensus $6.20. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ZKIN

ZK International Group

$8.23

0.07 (0.86%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Hot Stocks
ZK International Group invited by Shenzhen Water Group »

ZK International Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Earnings
T-Mobile reports Q3 EPS 63c, consensus 46c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

EGL

Engility

$33.41

-0.11 (-0.33%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Hot Stocks
Engility wins $14M contract from Defense Intelligence Agency »

Engility Holdings won a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 09

    Nov

  • 14

    Dec

ROKU

Roku

$21.87

-0.16 (-0.73%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Initiation
Roku initiated  »

Roku initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

DHI

D.R. Horton

$42.67

0.14 (0.33%)

07:30
10/23/17
10/23
07:30
10/23/17
07:30
Recommendations
D.R. Horton analyst commentary  »

D.R. Horton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.